ITRM
The Potential Rise in the Price of Iterum Therapeutics Plc (ITRM) following insiders activity
Anna Perez
Iterum Therapeutics Plc’s recent filing unveils that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov ...
Gabelli & Co gives a Hold recommendation for Iterum Therapeutics Plc (ITRM)
Anna Perez
Iterum Therapeutics Plc’s recently made public that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov ...
ITRM stock rated a Hold by Gabelli & Co
Roman Campbell
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
A Guide To The Risks Of Investing In Iterum Therapeutics Plc (ITRM)
Jaxson Clark
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
Understanding the Risks of Investing in Iterum Therapeutics Plc (ITRM)
Jaxson Clark
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
